Superior Group of Companies (SGC) Q4 2025 earnings summary

Executive summary

• Fourth quarter net sales rose to $146.6 million from $145.4 million year-over-year, with net income increasing to $3.5 million from $2.1 million and EBITDA up 19% to $8.6 million from $7.3 million.

• Full-year 2025 net sales reached $566.2 million, with net income of $7.0 million and EBITDA of $25.7 million.

• Operates three diversified businesses: Branded Products, Healthcare Apparel, and Contact Centers, each in large, growing markets with high customer retention.

• Delivered a consolidated revenue CAGR of 7% from 2019 to 2025, with annualized revenue growth of 10% since 2015.

• Maintains a solid balance sheet, uninterrupted dividend since 1977, and significant insider ownership.

Financial highlights

• Q4 2025 net sales: $146.6 million (up 0.8% year-over-year); net income: $3.5 million (up 67% year-over-year); EPS: $0.23 (up from $0.13).

• Q4 EBITDA: $8.6 million (up from $7.3 million); EBITDA margin: 5.9% (up from 5.0%).

• Full-year 2025 net sales: $566.2 million; net income: $7.0 million (down from $12.0 million in 2024); EPS: $0.46 (down from $0.73).

• Segment EBITDA for 2025: Branded Products $33.3 million (9.2% margin), Healthcare Apparel $6.1 million (5.3%), Contact Centers $9.2 million (10.0%).

• Gross margin for 2025: $212.9 million; EBITDA margin consolidated: 4.5%.

Outlook and guidance

• 2026 net sales forecasted at $572–$585 million, up from $566.2 million in 2025.

• 2026 EPS guidance: $0.54–$0.66, up from $0.46 in 2025.

• Growth is expected to be back-end weighted, with all three segments projected to grow if macro conditions normalize.

• Focus on expanding production, digital technologies, and infrastructure to support organic growth.